EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Efficacy of ivermectin treatment of Loa loa filariasis patients without microfilaraemias


, : Efficacy of ivermectin treatment of Loa loa filariasis patients without microfilaraemias. Annals of Tropical Medicine and Parasitology 88(1): 93-94



Accession: 002367653

PMID: 8192523

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Shenoy, R.K.; Varghese, J.; Kuttikkal, V.V.; Kumaraswami, V., 1998: The efficacy, tolerability and safety of diethylcarbamazine-fortified salt in the treatment of the microfilaraemias of brugian filariasis: an open, hospital-based study. Cooking salt fortified with diethylcarbamazine (DEC) has been successfully used to control lymphatic filariasis in several parts of the world. The kinetics and efficacy of DEC-fortified salt in clearing microfilaraemias of Brugia malayi and the sa...

Makunde, W.H.; Kamugisha, L.M.; Massaga, J.J.; Makunde, R.W.; Savael, Z.X.; Akida, J.; Salum, F.M.; Taylor, M.J., 2003: Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis. Background: In order to use a combination of ivermectin and albendazole for the elimination of lymphatic filariasis, it is important to assess the potential risk of increased adverse events in individuals infected with both lymphatic filariasis an...

Kumaraswami, V.; Ottesen, E.A.; Vijayasekaran, V.; Devi, U.; Swaminathan, M.; Aziz, M.A.; Sarma, G.R.; Prabhakar, R.; Tripathy, S.P., 1988: Ivermectin for the treatment of Wuchereria bancrofti filariasis. Efficacy and adverse reactions. Ivermectin treatment was evaluated for efficacy and side effects in 40 patients in South India who had microfilaremia and bancroftian filariasis. Ivermectin was administered once orally at four dose levels (range, 25 to 200 micrograms/kg), and at...

Hassan, M.M.; Bahgat, M.A.; Ali, A.E.; Saleh, A.; El-Shafae, O.K.; Abdel-Ghaffar, M.M.; Mowafy, N.M., 2001: Circulating filarial antigens for monitoring the efficacy of ivermectin in treatment of filariasis. 73 patients (aged 14-43 years) with asymptomatic Bancroftian filariasis from Sharkia Governorate, Egypt, were included in the study. All patients had microfilaria in their blood films. The patients were randomly divided into 2 groups: the ivermect...

Ismail, M.M.; Premaratne, U.N.; Abeyewickreme, W. et al., 1991: Treatment of bancroftian filariasis with ivermectin in Sri Lanka: evaluation of efficacy and adverse reactions. In a double-blind, dose-ranging study 40 adult males, all asymptomatic microfilaraemics, were hospitalised and treated with a single ivermectin 20, 50, 100 or 200 micro g/kg dose. All patients showed a marked decline in microfilaraemia 14 hours af...

Ali, M.; Afzal, M.; Verma, M.; Bhattacharya, S.Misra.; Ahmad, F.J.; Samim, M.; Abidin, M.Z.; Dinda, A.K., 2014: Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model. The present study reports on the antifilarial activity of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-IVM) against human lymphatic filariid Brugia malayi in rodent host Mastomys coucha. Nano-IVM was prepared and opti...

Thomsen, E.K.; Sanuku, N.; Baea, M.; Satofan, S.; Maki, E.; Lombore, B.; Schmidt, M.S.; Siba, P.M.; Weil, G.J.; Kazura, J.W.; Fleckenstein, L.L.; King, C.L., 2016: Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis. Available treatments for lymphatic filariasis (LF) are limited in their longterm clearance of microfilaria from the blood. The safety and efficacy of a single-dose triple-drug therapy of the antifilarial drugs diethylcarbamazine (DEC), ivermectin...

Ismail, M.M.; Jayakody, R.L.; Weil, G.J.; Nirmalan, N.; Jayasinghe, K.S.A.; Abeyewickreme, W.; Sheriff, M.H.R.; Rajaratnam, H.N.; Amarasekera, N.; Silva, D.C.L. de; Michalski, M.L.; Dissanaike, A.S., 1998: Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. In a trial of 50 male asymptomatic microfilaraemic subjects with Wuchereria bancrofti infection, the safety, tolerability and filaricidal efficacy of a single dose of albendazole (600 mg) alone or in combination with ivermectin (400 micro g/kg) or...

Moulia-Pelat, J.P.; Glaziou, P.; Nguyen, L.N.; Chanteau, S.; Martin, P.M.V.; Cartel, J.L., 1993: Long-term efficacy of single-dose treatment with 400 mu-g.kg-1 of ivermectin in bancroftian filariasis: Results at one year. In April 1992, a safety trial was performed with a single dose of ivermectin 400 mu-g cntdot kg-1 (IVER 400). In 37 bancroftian filariasis carriers, 6 and 12 months after IVER 400 treatment, the microfilaremia recurrences were 3.2% and 13.5%, resp...

Cartel, J.L.; Sechan, Y.; Boutin, J.P.; Celerier, P.; Plichart, R.; Roux, J.F., 1990: Ivermectin for treatment of bancroftian filariasis in French Polynesia: efficacy in man, effect on transmission by vector Aedes polynesiensis. Forty male Polynesian Wuchereria bancrofti carriers, aged between 18 and 50 years, with microfilarial (mf) counts >=20/ml were treated with a single dose of ivermectin (50, 100, 150 or 200 micro g/kg). Following therapy, mf levels fell to <1...